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Abstract
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Clinical trials often rely on echocardiographic measures of left ventricular (LV) size and function
as surrogate end-points. However, the quantitative impact of factors that affect reproducibility of
these measures is unknown. To address this issue, the NHLBI-funded Pediatric Heart Network
designed a longitudinal observational study of children with known or suspected dilated
cardiomyopathy (DCM) aged 0–22 years from 8 pediatric clinical centers.
Methods—Clinical data were collected together with 150 echocardiographic indices of LV size
and function. Separate observers performed duplicate echocardiographic imaging. Multiple
observers performed measurements from three cardiac cycles to enable assessment of intra and
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interobserver variability. We studied the impact of beat averaging (BA), observer type (local vs.
core) and variable type (areas, calculations, dimensions, slopes, time intervals and velocities) on
measurement reproducibility. The outcome measure was %error (100 × difference/mean)
Results—Of 173 enrolled subjects, 131 met criteria for DCM. BA, variable type and observer
type all impacted %error (p<0.0001). Core inter-observer %error (median 11.4, 10.2 and 9.3% for
1-, 2- and 3-BA, respectively) was approximately twice the intra-observer %error (median 6.3, 4.9
and 4.2% for 1-, 2- and 3-BA, respectively). Slopes and calculated variables exhibited high %error
despite BA. Chamber dimensions, areas, velocities and time intervals exhibited low %error.
Conclusions—This comprehensive evaluation of quantitative echocardiographic methods will
provide a valuable resource for design of future pediatric studies. BA and a single core lab
observer improve reproducibility of echo measurements in children with DCM. Certain
measurements are highly reproducible, while others, despite BA, are poorly reproducible.

Introduction

NIH-PA Author Manuscript

Left ventricular (LV) size and function are important independent predictors of outcome in
numerous forms of cardiovascular disease. In children, echocardiography is the primary
modality used to assess ventricular function, and echocardiographically derived
measurements are commonly used as endpoints in pediatric clinical trials. Although there is
extensive experience with this technology, there are few quantitative data concerning
reproducibility of these measurements, particularly in children with dilated cardiomyopathy
(DCM).(1) This issue is particularly problematic because of the wide range of factors that
are known to affect this reproducibility. Patient age and habitus are known to be important,
as is disease status. Less commonly appreciated is the evolution of technology over time,
which requires that this issue be addressed anew with each new generation of
echocardiographic equipment. Potential sources of variability in echocardiographic
measurements include all of the following:

NIH-PA Author Manuscript

1.

Interpatient variability: differences between patients related to patient-specific
factors such as age, body size, variation in cardiac output, physical training, etc.,
and disease-specific factors such as severity of disease and treatment status;

2.

Interstudy variability: longitudinal variation within an individual due to physiologic
factors, variation in treatment, and change in disease status;

3.

Intrastudy variability: short term (beat-to-beat) variations in the same patient
secondary to respiratory effects or change in position, and minute-to-minute
variation related to factors such as change in emotional state;

4.

Technical factors that modulate each of the foregoing, which include:
a.

Variability due to differences in echocardiographic and image analysis
equipment and whether or not sedation was used;

b. Intra- and interobserver variability in data (image) acquisition;
c.

Intra- and interobserver variability in measurements, including frame
selection and structure identification.

In addition to facilitating efforts to improve reproducibility of echocardiographic data,
evaluation of variability serves to identify which measured or calculated variables may be
preferable and which are too poorly reproducible to be clinically reliable. Finally, design of
clinical trials requires estimation of the number of patients that must be enrolled, which
requires knowledge of total variability.

J Am Soc Echocardiogr. Author manuscript; available in PMC 2013 August 01.
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This report describes the design and initial findings of the Ventricular Volume Variability
(VVV) study, a multicenter study in children with DCM. We present first the overall study
aims, the complex study design implemented to address these aims, and the study results
specific to the impact of beat averaging. There are few data that examine the impact of beat
averaging and variable type on the inter- and intra-observer reproducibility of
echocardiographic measurements.(2–5) We elected to perform these analyses before
addressing the primary aim of the overall study, so that decisions regarding beat averaging
could be applied to all subsequent study analyses.
The VVV Study was conducted to address the following aims:
Primary aim.
To determine the interstudy variability of echocardiographically-derived LV enddiastolic volume z-score, mass z-score, and ejection fraction z-score in pediatric
patients with DCM; more specifically, the variance at a single point in time as well
as the variance of change in measurements over time.
Secondary aims.

NIH-PA Author Manuscript

1.

To determine the relative magnitude of the various sources of variability in
echocardiographic outcomes in order to optimize operational procedures that
can minimize variance.

2.

To determine the interstudy variability of echocardiographically-derived
indices of LV systolic and diastolic function.

3.

To determine the relationship of clinical status, including treatment, to the
interstudy variability and repeatability of echocardiographic measurements.

The specific analysis presented in this report had 3 aims: 1) to determine whether the choice
of single-beat analysis or 2- or 3-beat averaging has an influence on inter-observer and intraobserver reproducibility of echocardiographic measurements and calculated variables; 2) to
examine the effect of the type of echocardiographic variable on reproducibility as it pertains
to beat averaging; and 3) to evaluate the effect of beat averaging on the reproducibility of
measurements that were performed at the local centers compared to those performed at the
core laboratory.

Materials and methods
Subjects

NIH-PA Author Manuscript

Pediatric patients with known or suspected DCM were enrolled at the time of
echocardiographic presentation at each of the 8 study centers (see Appendix:
Acknowledgements) between May 2005 and July 2007. Inclusion criteria were age <22
years, known or suspected DCM, disease duration >2 months, anticipated longitudinal
follow-up to occur at the same institution, and informed consent. Exclusion criteria (listed in
detail in Appendix Figure 1) included other forms of cardiomyopathy and congenital heart
disease. Exclusion criteria also included non-compaction (due to an inability to reliably
define LV endocardial borders), excessive non-sinus rhythm (due to excess beat-to-beat
variance) and hemodynamic instability (due to the intent to assess longitudinal natural
history).
Training
The study principal investigator from each clinical site along with one or more designated
site sonographers attended an in-person training session that included protocol review and
demonstration of the image acquisition techniques. The measurement methods were
J Am Soc Echocardiogr. Author manuscript; available in PMC 2013 August 01.
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reviewed in detail with the site principal investigator and the designated primary
sonographer for the study, one of whom performed all of the local measurements. Each
center performed and submitted three practice echocardiograms to the core lab for review
and feedback. After approval, enrollment commenced.
Demographics
Height and weight were measured and body surface area (BSA) was calculated using the
Haycock formula.(6) Systolic, diastolic, and mean blood pressures were recorded 4 times
with the patient in a recumbent position using an automated blood pressure device. The
values from the first recording were discarded and the average value of the other 3
measurements was calculated for each pressure.
Echocardiographic acquisition

NIH-PA Author Manuscript

All echocardiograms were performed according to a standardized protocol with acquisition
of the images listed in Appendix Table 1. Each center designated one or more “primary”
sonographers who participated in hands-on study training sessions. For each
echocardiographic evaluation, image acquisition was performed by a “primary”
echocardiographer and then a second image acquisition was independently performed by
any available experienced sonographer (who had not necessarily participated in the study
training sessions). The second set of images was acquired immediately following the first.
Eligibility for longitudinal evaluation

NIH-PA Author Manuscript

A standardized set of measurements was performed at the study center on the primary data
acquisition and the results of these measurements were used to determine eligibility for
longitudinal echocardiographic evaluation. Patients who met criteria for the diagnosis of
DCM based on the inclusion and exclusion criteria listed above who also were found to have
both LV dilation (defined as end-diastolic dimension >5.5 cm or end-diastolic dimension zscore >2) and LV dysfunction (defined as ejection fraction <50%, shortening fraction <28%,
or z-score for either of <-2) were judged eligible for longitudinal assessment (Appendix
Figure 2). Eligible patients had repeat echocardiographic assessment according to the study
protocol on return visits up to 18 months following enrollment, providing no indication for
withdrawal from the study was met. Indications for withdrawal were death, cardiac
transplantation or LV reduction surgery, institution of an LV assist device including
extracorporeal membrane oxygenator support, and patient or physician preference. Each
subject, therefore, was expected to have 2 sets of echocardiographic images at the time of
study enrollment and 2 sets from at least one follow-up visit. The target timing for the
follow-up echocardiogram was 12 months, as this was considered to be a likely interval to
assess change in a randomized trial. In the completed study, the mean time between paired
echocardiograms using the follow-up echocardiogram closest to the 12-month target was
9.1±3.5 (median 9.6, range 2 to 18) months.
Partial participation group
Subjects who had baseline image acquisition but were then found to not meet criteria for
longitudinal evaluation were excluded from further participation, but their baseline images
were included in the analyses of reproducibility, thereby permitting evaluation of
reproducibility over a broader range of ventricular size and function in addition to enhancing
the analysis of the impact of severity of dysfunction on reproducibility.
Echocardiographic analysis
A standardized measurement protocol that included a total of 150 measurements and
calculated variables was performed at the core laboratory for each of 3 cardiac cycles (450
J Am Soc Echocardiogr. Author manuscript; available in PMC 2013 August 01.
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measurements total) for each set of echocardiographic images (Appendix Table 2).
Measurements were categorized as areas (9 variables), calculated variables derived from 2, 3
and 4 measured variables (19, 25 and 21 variables respectively), dimensions (16 variables),
ECG time intervals and heart rates (7 and 9 variables respectively), integrals (1 variable),
slopes (4 variables), Doppler and M-mode time intervals (22 variables) and Doppler
velocities (17 variables). A single observer at each center performed the measurements for
the primary image acquisition at the initial and follow-up visits using locally available
technology, and submitted the results to the data coordinating center. The dataset
constructed at the local centers is comprised of 119 of the above 150 measurements and
derived indices. The images from both the primary and secondary image acquisitions from
each subject visit were submitted to the data coordinating center where they were blinded to
study date and patient identification and coded prior to transmission to the
echocardiographic core lab for analysis (Appendix Figure 1). Image capture and transfer
included video tape, analog-to-digital converted images, and DICOM, depending on the date
and the center. All echocardiographic measurements were performed using custom DICOM
software (EchoTrace, Marcus Laboratories, Boston, MA) At the core lab, a primary and
secondary core lab observer analyzed both the primary and secondary image acquisitions by
using the same measurement protocol (Appendix Table 2). In addition, the primary core lab
observer repeated the measurements on blinded sets of the primary images at 1 month and 1
year following the original measurements. Primary and secondary image sets acquired at
follow-up evaluations of fully eligible subjects were each analyzed by both the primary and
secondary core lab observers. Altogether, there were 12 different categories of
echocardiographic data sets for statistical comparison, as listed in Appendix Table 3.
Image quality assessment
In addition to performing the measurements, the primary core lab observer performed a
quality assessment for each of the images in Appendix Table 1. The image grading system
was defined as:

NIH-PA Author Manuscript

1.

Excellent: the full extent of the structure boundary of interest was clearly defined
with no visible gaps, zoom-mode was activated to maximize image resolution for
2D structures and Doppler signals were scaled proportional to image size.

2.

Good: the full extent of the structure boundary of interest was contained within the
image sector with only brief gaps requiring interpolation and for Doppler signals
there was minimal baseline artifact.

3.

Fair: nearly the entire boundary of the structure of interest was contained and
adequately visible but minor extrapolation beyond the imaging sector was required,
boundaries had identifiable but indistinct borders and prominent baseline artifact
was present on Doppler recordings.

4.

Poor: significant portions of the boundary of interest required interpolation from
visible but indistinct segments or more than a short segment of the boundary was
outside of the imaging sector.

5.

Unusable: the structure was not recorded or too poorly defined to be measured.

Additionally, each echocardiogram was also evaluated for a) trabeculations that could
potentially interfere with definition of the LV apical endocardium; b) qualitative assessment
of regional wall motion abnormalities, and c) septal displacement resulting in a non-circular
short axis LV configuration.

J Am Soc Echocardiogr. Author manuscript; available in PMC 2013 August 01.
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The medical records of all subjects were reviewed at the time of enrollment, at each
subsequent echocardiogram, and at 18 months post-enrollment for medical history including
medical therapy and changes in medical therapy, procedures, interventions, adverse events,
and symptom and cardiac transplantation listing status.
Statistical Analysis

NIH-PA Author Manuscript

The primary aim of this study was to determine the interstudy variability of
echocardiographically-derived LV measurements in pediatric patients with DCM, and in
particular, the variance of LV ejection fraction z-score at a single point in time and the
variance of change in z-score between two time points. The required sample size to estimate
the population standard deviation to within a prespecified tolerance is n = z21−σ/2 / (2d2),
where d = allowed fractional deviation from σ, the population sample standard deviation.(7)
To construct a two-sided 95% confidence interval for σ that deviates no more than 15%
from the true value requires n = 86. It was estimated that 25–30% of subjects would
withdraw, have echocardiograms conducted under differing sedation conditions, or have
incomplete baseline/follow-up echocardiogram pairs for other reasons. Therefore, the target
sample size was set to be 120 patients with qualifying baseline echocardiograms to ensure
that 86 of these have paired interpretable echocardiograms (a total of 172 echocardiograms)
performed under similar conditions. In actual execution, the study enrolled 173 patients, of
whom 131 were eligible for longitudinal evaluation, to ensure that 86 qualifying
echocardiogram pairs would be obtained. A total of 107 of these subjects had at least one
follow-up echocardiogram submitted, and 97 of these formed qualifying echocardiogram
pairs. The 10 subjects with non-qualifying pairs met one of the following criteria: no
secondary image acquisition, incorrect sonographer, or inconsistent sedation status between
the two echocardiograms.
VVV Study Analysis Plan
Based on the study design shown in Appendix Table 3, for any given echocardiographic
parameter, there were 21 or 15 sets of measurements from each study visit (3 sequential
cardiac cycles × 7 different readings for a baseline visit and 5 different readings for a
follow-up visit). The analyses of these data sets include the following comparisons of
interest to assess:
Interacquisition observer variability:
1) Images acquired by different observers and measured by the same observer

NIH-PA Author Manuscript

Intraobserver variability:
2) Same set of images measured twice by the same person spaced by 1 month
Intraobserver drift:
3) Same set of images measured twice by the same person spaced by 12 months
Interobserver variability:
4) Same set of images, measurements by one core lab observer versus measurements by
second core lab observer
5) Same set of images, measurements by core lab versus measurements by study center
Changes over time in cardiac function holding acquisition observer and measurer
constant:
6) Images acquired by the same observer and measured by the same observer

J Am Soc Echocardiogr. Author manuscript; available in PMC 2013 August 01.
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The outcome measure was the percent (%) error of the mean. Echocardiographic
measurements using the primary image acquisition from all baseline studies were included
in analysis. For each evaluation of reproducibility between 2 measurements of the same
entity, the difference (‘error’) between the 2 measurements was divided by the mean of
those two measurements. Three settings were used to compare the following 2
measurements:
•

Core laboratory inter-observer variability: Primary vs. secondary observer

•

Core laboratory intra-observer variability: Primary observer immediate vs. 1-month
reading

•

Core vs. local laboratory inter-observer variability: Primary core laboratory
observer vs. clinical center observer

NIH-PA Author Manuscript

We fit a mixed effects model with estimates obtained by restricted maximum likelihood with
a compound symmetry covariance structure (fixed effect for beat averaging method and
random effect for subject) to assess whether % error significantly differed for single- vs. 3beat average and 2- vs. 3-beat average, for inter-observer, intra-observer and local vs. core
laboratory comparisons. We fit a mixed effects model with unstructured covariance to assess
whether, for each variable type, based on 3-beat-averaged measurements, inter-observer %
error differed for local/core vs. core/core % error estimates, and for core lab inter- vs. intraobserver % error.

Results
Patient evaluation and enrollment are summarized in Appendix Figure 2. A total of 275
subjects with known or suspected DCM were screened. Of those, 194 were eligible for the
initial screening echocardiogram, 173 (89%) consented to participation and underwent data
recording, and 131 were confirmed to have chronic DCM. There were an additional 38
subjects enrolled who did not meet criteria for LV dilation and/or dysfunction but who did
not meet any exclusion criteria (partial participation). The data from these subjects were also
included in the analysis of intra- and inter-observer variability.
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The comparison of the 4 groups defined by eligibility status is presented in Table 1. Because
only subjects who met criteria for significant DCM were fully eligible, ventricular size was
markedly larger and ventricular function was markedly worse in the fully eligible group.
The severity of disease in this group is apparent, with a mean LV end-diastolic dimension
4.9 standard deviations above, and a LV ejection fraction 5.0 standard deviations below, the
normal mean value. A comparison of the etiology of cardiomyopathy in the partial and full
participation is presented in Table 2. For both groups, idiopathic and adriamycin-associated
cardiomyopathies were the most common etiologies. A comparison of clinical status (Ross
classification for children under age 5 years and New York Heart Association [NYHA]
status for children over age 5) is presented in Table 3. Despite the lesser severity of
echocardiographic manifestations of cardiomyopathy in the partial participation group, the
distribution of clinical severity was not significantly different. However, in subjects > 5
years old, qualitatively more partial participation subjects were in NYHA class I (72%) than
were full participation subjects (59%).
Appendix Table 2 presents the yield with respect to successful core laboratory measurement
of the echocardiographic parameters in this study. All parameters were measurable at least
94% of the time, with the exception of the time interval between mitral regurgitation
velocity of 1 and 3 msec (58%), spectral tissue Doppler diastolic summation wave velocity
(left, 88%; septal, 80%; right, 93%), and peak early diastolic velocity/peak mitral inflow
J Am Soc Echocardiogr. Author manuscript; available in PMC 2013 August 01.
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(left, 64%; septal 79%; average, 61%). This information may be a useful consideration in
endpoint selection for future studies.
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Beat averaging: Analyses of core laboratory measurements
Beat averaging and reproducibility—Summary statistics for the % error for singlebeat, 2- and 3-beat averaging methods for inter- and intra-observer reproducibility for all
150 variables are reported in Table 4. Overall, the magnitude of intra-observer % error was
approximately half that of inter-observer % error (p<.001). As the number of beats that were
averaged was increased, both inter- and intra-observer % error decreased.
Variable type and inter-observer reproducibility—Inter-observer reproducibility was
significantly affected by the type of echo variable and by beat-averaging method
(p<0.0001). Figure 1 displays plots of mean inter-observer reproducibility by type of echo
variable and by beat-averaging method. Measurements of slope and calculations involving 2,
3 and 4 measured variables had the lowest inter-observer reproducibility (highest % error),
e.g., the median of median % error was 39% for slopes and 14% for variables calculated
from 4 measurements.
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Variable type and intra-observer reproducibility—Intra-observer reproducibility was
significantly affected by the type of echo variable and by beat-averaging method
(p<0.0001). Figure 2 displays plots of median intra-observer reproducibility by type of echo
variable and by beat-averaging method. Measurements of slope and calculations involving 4
measured variables had the lowest intra-observer reproducibility (highest % error), e.g., the
median of median % error was 16% for slopes and 5% for measurements calculated from 4
measured variables.
Variables with best and worst reproducibility—Even when 3-beat averaging was
used, a wide range of % error was found for both inter- and intra-observer analyses (Figure
3). The 20 variables with the highest % error had inter-observer mean % error ranging from
17.7 to 46.7%, while intra-observer mean % error ranged from 8.6 to 23.2% (Table 5). Of
these 20 variables, 13 were common to both inter- and intra-observer categories. Calculated
variables and tissue Doppler measurements of isovolumic acceleration consistently exhibited
large % errors.
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Of the variables with the lowest inter- and intra-observer % error, many were measurements
of heart rate. These were used as ‘internal controls’ and were not analyzed further. Table 6
lists the 20 variables with the lowest % error after excluding heart rate measurements (range
0.9% to 4.8% for inter-observer and 0.33% to 2.1% for intra-observer). Of these 20
variables, 9 were common to both inter- and intra-observer categories. Measurements of LV
internal chamber dimensions and traced areas consistently exhibited low % errors.
Comparison of core laboratory to local measurements—Summary statistics for
the % error for single-beat, 2- and 3-beat averaging methods for core vs. local-observer
reproducibility for all 119 variables are reported in Table 7. Overall % error decreased as the
number of averaged beats increased. Figure 3 and 4 display the reproducibility of variables
between a single observer at the core laboratory, between 2 observers at the core laboratory,
and between a core lab observer and a single observer at the local center, plotting % error by
type of echo variable for the 3 beat-averaging method. As previously noted, measurements
of slope and calculated variables exhibited the greatest % error. Despite 3-beat averaging,
many variables exhibited high % error (Table 8, left column). Mean % error among the 20
variables with the highest % error ranged from 23.0% to 56.4%. Calculated variables, tissue
Doppler measurements of isovolumic acceleration and M-mode measurements of LV wall

J Am Soc Echocardiogr. Author manuscript; available in PMC 2013 August 01.
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thickness exhibited high % errors. Of these 20 variables, 11 also appeared in the list of 20
variables with the highest % inter-observer error (core laboratory, Table 5). These consisted
of tissue Doppler measurements of isovolumic acceleration, and calculated variables derived
from 4 variables. Of the variables with the lowest inter- and intra-observer % error, many
were measurements of heart rate. Table 8 (right column) lists the 20 variables with the
lowest % error after excluding heart rate measurements. Of these 20 variables, 18 also
appeared in the list of 20 variables with the lowest % inter-observer error (core laboratory,
Table 6). Measurements of LV internal chamber dimensions and traced areas consistently
exhibited low % errors.
Comparison of inter- to intra-observer reproducibility—Table 9 summarizes the 3beat averaged median % error by class of echo variable, using the classification of variables
that was detailed earlier. For all categories of variables, core lab intra-observer % error was
significantly lower than core lab inter-observer % error (p=0.004 for slopes and p<0.001 for
all others). For all categories of variables, core lab inter-observer % error was significantly
lower than local vs. core lab % error (p=0.018 for the ‘integral’ variable type and p<0.001
for all others).

NIH-PA Author Manuscript

Optimization of laboratory design—Having observed that a single observer design
improves reproducibility for all variables, we evaluated whether inter-observer variability
was significantly less for core-versus-core comparison (figure 3) compared to core-versuslocal comparison (figure 4). Overall, core lab, same reader %error is 52% that of the %error
for core lab, 2 reader model (6.37 vs. 12.27). Core lab, 2-reader %error is 78% that of coreversus-local model (12.27 versus 15.69). Thus, the greatest improvement in reproducibility
was achieved with a single-reader core lab model with more modest benefits associated with
a multi-reader core lab model.

Discussion
Selection of patients
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The primary motivation for this observational study was to provide the information required
to design a medical interventional trial for DCM in children. Because of the high frequency
of early death or complete recovery in children with acute onset DCM (8,9), we targeted
enrollment of children with chronic, relatively stable disease, excluding acute onset disease
and patients listed or likely to be listed for transplantation. In order to optimize the
likelihood of detecting improved outcomes, we excluded patients with known confounders
of assessment of ventricular function, including paced rhythm, noncompaction, and complex
congenital heart disease. We also excluded co-morbid conditions likely to limit survival
independent of cardiomyopathy. We chose to include the echocardiograms performed at
initial evaluation in the subjects whose ventricular function was too normal to justify
inclusion in the longitudinal evaluation. While these echocardiograms did not contribute to
the study aim of assessing interstudy variability (within-subject change over time), including
these subjects expanded the range of ventricular size and function that is included in the
reproducibility analysis. This allows us to address the issue of reproducibility over the full
clinical spectrum, and strengthens the analysis of the impact of disease severity on
reproducibility.
Selection of endpoints
Because the annual incidence of DCM in children is 10-fold lower than in adults with a 4year freedom from death or transplant of 55% (10), it would be difficult to recruit a
sufficiently large study population to detect a significant reduction in these hard endpoints in
a reasonable time frame. Indeed, despite including 8 clinical centers it required 2.25 years to
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enroll 131 subjects into the current observational study. Echocardiographic measures that
are correlated with clinical events can be valuable surrogate outcomes that provide enhanced
statistical power, and are particularly useful in shorter-term studies. However, published
information critical to achieving accurate sample size calculations is lacking. The literature
contains some estimates of the variance of change in LV ejection fraction, but they were
based on adult data. There are estimates of the variance of LV ejection fraction in children,
but little from longitudinal data that would provide information on the correlation of
measurements over time. We also recognized that the standard deviation estimates ranged
widely depending on whether ejection fraction was measured locally or centrally. Hence, the
current study was designed to obtain an estimate of variance for change in LV ejection
fraction in children with DCM, and to investigate in detail the relative contributions of
numerous factors to the variance. The goal was to then use this information in the design of
future pediatric trials.
Reproducibility of echocardiographic endpoints
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Any variance in end-point assessment impedes detection of treatment effect, emphasizing
the importance of maximizing reproducibility of echocardiographic endpoints. It is common
practice in clinical trials to make use of core laboratories, standardized protocols, and
personnel training to maximize reproducibility. Despite this, available adult data indicate
that the magnitude of the technique-related variance imposes a significant penalty in terms
of sample size requirements for studies based on echocardiographic endpoints. For example,
echocardiographic assessment of m-mode LV mass is reported to have intra-sonographer
variance of 10%, inter-sonographer variance of 10%, intra-observer variance of 10% that
increases to 16% when the same observer repeats the interpretation 5 years later, interobserver variance of 14%, and a frequency of non-measurable echocardiograms of 33%.(11)
The reliability of the measurements is inversely related to age and body mass index,
predicting a potentially better performance of the technology in children. Although studies
comparing core laboratory versus clinical center interpretation of echocardiograms in
children are available, studies examining the comparative performance of the full spectrum
of indices of ventricular function and the relative importance of the various sources of
variance have not been performed. (1) In addition, the technical advances in
echocardiographic equipment and the general adoption of DICOM image storage might well
diminish the relevance of these older studies.
Sources of measurement variability

NIH-PA Author Manuscript

Some sources of variability are nearly impossible to quantify or control, such as variance
secondary to differences between machines, transducers, and machine settings, due to the
variety of ways in which these factors can be combined. In contrast, there are other sources
of variability that can potentially be reduced through study design modifications, such as use
of a core laboratory or expanded data collection to yield beat-averaged measurements. These
design modifications invariably increase costs, and the cost versus benefit analysis that is
needed involves comparing the reduction in cost related to patient enrollment versus the cost
escalation related to end-point determination. To that end, we designed this study to assess
inter-observer, intra-observer, and inter-acquisition reproducibility, in addition to the impact
of controllable factors such as beat averaging and potentially controllable factors such as
image quality, as well as non-controllable factors such as age, body mass index, and severity
of disease.
Beat averaging
The impact of beat averaging on the reproducibility of echocardiographic measurements has
not been evaluated comprehensively in either adults or in children. While it is intuitive that
averaging multiple beats should lead to improved reproducibility, this has logistic
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implications that are increasingly relevant in practice. Studies in adult patients have
demonstrated beat-to-beat variations in echocardiographic measurements of cardiac
dimensions, volumes and Doppler waveforms based on technologies for image acquisition,
storage and analysis which, while appropriate to the era, would be considered dated today.
(12–16) These studies demonstrated that respiratory effects on ventricular filling were an
important physiologic source of beat-to-beat variation and concluded that in order to
minimize the impact of beat-to-beat variability, measurements should be made using breath
holding, or be performed at end-expiration, or that beat averaging is necessary. Neither
breath holding nor acquisitions that coincide with end-expiration are practical alternatives in
multi-center studies, particularly in children who may be unable to cooperate. We elected to
evaluate the impact of averaging up to 3 beats because at rest, the respiratory cycle generally
encompasses three cardiac cycles. In recent years, the wide availability of echocardiography
as a bedside tool has been coupled with an expansion of the number and type of
measurements that can be made on an echocardiogram. Interestingly, two recent randomized
clinical trials have demonstrated that the effects of medications such as carvedilol and
enalapril on echocardiographic measures of cardiac function in children vary significantly
from those seen in adults. (17,18) Together, these studies point to the need for evaluating
whether, in the contemporary era, factors such as the number of observers, beat averaging
and variable type have an impact on the reproducibility of echocardiographic measurements
that are in clinical use in children with DCM.

NIH-PA Author Manuscript
NIH-PA Author Manuscript

The current study revealed a wide range of % error for echocardiographic measurements,
with high % errors for measurements of slope and variables that are derived from 2, 3 or 4
measured quantities. The high % error of local versus core laboratory measurements for all
types of variables points to the importance of a core laboratory for performing
measurements from the perspective of reproducibility of measurements in multicenter
studies. In addition, even within the standardized framework of a core laboratory, in order to
enhance reproducibility, a single core lab observer is preferable to multiple core lab
observers. Similarly, single-beat measurement leads to high % error, which decreases with
the use of beat averaging. These findings have important implications for the structure,
design and logistics of core laboratory analysis of echocardiographic measurements. The
reproducibility of measurements of slopes and calculated echocardiographic variables in the
current study is remarkably lower than that reported from single-center studies. (19,20) One
potential explanation is that in the current study, all core laboratory measurements were
performed using a single echocardiographic measurement program but the image acquisition
and the measurements performed at the clinical sites were performed using whatever
platform was in use at their location. This approach was used because the use of vendorspecific technologies for image acquisition and analysis imposes fundamental limitations on
their applicability to multi-center clinical trials. In an era of increasing logistic demands, the
automation of echocardiographic measurements using vendor-independent computerized
algorithms may provide for more efficient beat averaging and, eventually, potentially
improve their reproducibility. (21–23) While measurements of slopes and calculated
variables may play an important role in clinical practice, these findings sound a cautionary
note in the selection of such variables as echocardiographic endpoints in clinical trials.
Limitations
Modalities such as 3D echocardiography and myocardial deformation imaging were not
studied because they were not widely available at the time that the study commenced (2005).
We did not examine other sources of variability; these will be the topic of future analyses of
this project.
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In a multi-center study, 3-beat averaging, the use of a core laboratory and a single observer
yield better reproducibility for echo measurements in children with DCM. Despite beat
averaging, measurements of slope and some calculated variables remain poorly
reproducible. In contrast, measurements of ventricular chamber dimensions, traced areas and
time intervals are highly reproducible. These findings have implications for study design and
power, choice of endpoint and core lab structure in clinical trials of pediatric heart disease.
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Figure 1.
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Comparison of the mean core laboratory inter-observer % error (on the Y axis) for singlebeat, 2- and 3-beat averages for all 150 variables. These have been classified using the
schema detailed in the text, where A = area; C2, C3, C4 = calculated from 2, 3 and 4
variables respectively; D = dimension; I = integral; S = slope; T = Doppler time interval; V
= velocity, and R = heart rate. Measurements of slope and calculated variables exhibit the
greatest % error. A single asterisk means that only 1 versus 3 beat analysis yields a
statistically significant difference (Bonferroni testing), two asterisks mean 1 versus 2 and 1
versus 3 are different, and 3 asterisks means that 1 versus 2, 2 versus 3, and 1 versus 3 are
all different.
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Figure 2.
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Comparison of the mean core laboratory intra-observer % error (on the Y axis) for singlebeat, 2- and 3-beat averages for all 150 variables, classified using the schema detailed in
Figure 1. The pattern of percent error was parallel to that seen in inter-observer % error
shown in Figure 1. Significance is denoted using asterisks as described in figure 1. The
relative magnitude of the inter- versus intra-observer % error is illustrated in Figure 3.
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Figure 3.
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Distributions for the raw data for core laboratory inter- and intra-observer % error for 3-beat
averages of all 150 variables, classified into the categories described in figure 1. Each ‘box
and whiskers’ plot displays the median, upper and lower quartiles and upper and lower
extreme values of the % error. There was a significant upward skew of the distribution for
the majority of the variable types. There were wide ranges of % error for individual
variables, of the difference in intra and inter-observer percent error, and of the relative
frequency and magnitude of the outliers.
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Figure 4.

Distributions for the raw data for local center versus corelab inter-observer variability and
corelab versus corelab interobserver variability for the 119 variables measured at the local
center, using the classification schema detailed in Figure 1. Each ‘box and whiskers’ plot
displays the median, upper and lower quartiles and upper and lower extremevalues of the %
error.
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58.8%

0.0%

6.8%
0.0%
6.5%

Asian

Other

Hispanic

131

52.2±9.1
34.2%

−1.8(−3.2, −0.7)

85.4%

37.5±11.7

−4.7(−6.6, −3.1)

−5.0±2.3

93.1%

44.7%

−2.1±1.8

19.1±6.7

−6.9(−11, −4.4)

−8.2±5.7

47.3%

4.1(2.8,6.3)

4.9±2.8

15.2%

1.5%

5.3%

27.5%

65.6%

44.3%

8.7±6.0

9.9±6.1

9.3±6.0

28.6±7.1

−2.0(−4.3,−1.0)

−2.7±2.9

10.5%

1.6(0.9,2.1)

1.7±1.0

8.6%

2.6%

5.3%

EF <50%

4.8%

23.7%

68.4%

52.6%

8.8±6.1

10.7±4.8

Mean EF (%)

Median (Q1, Q3) z-score

Mean z-score

LV ejection fraction (EF)

SF < 28%

Mean SF (%)

Median (Q1, Q3) z-score

Mean z-score

LV shortening fraction (SF)

EDD > 5.5 cm

Median (Q1, Q3) z-score

Mean z-score

LV end-diastolic dimension (EDD)

Echocardiographic Inclusion Criteria (local measurements)

9.5%

14.9%

Black or African American

19.0%

78.4%

White

Race
66.7%

47.6%

8.1±6.2

Male

13.6±4.0

10.0±5.8

Female

9.8±5.4

38

Partial
Participation

Includes 81 patients ineligible by chart review and 4 patients ineligible by baseline echocardiogram

*

21
12.6±4.8

85
9.2±6.0
11.6±5.5

Not
Enrolled

Not
Eligible*

Male

Mean age at screening echo, yr

N

Characteristic

Full
Participation
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Patient Characteristics by Eligibility and Participation Status

<.001

<.001

<.001

<.001

<.001

<.001

<.001

<.001

<.001

<.001

<.001

0.19

0.55

0.65

0.04

0.65

0.05

P-value**
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LV=LV; Q1= first quartile; Q3=third quartile

p-value denotes comparison of Not Enrolled vs. Partial Participation vs. Full Participation
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Table 2

Primary cause of DCM in 169 enrolled subjects.
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Partial
Participation

Variable

Full
Participation

P-value
0.05

Etiology
Idiopathic

44.7%

66.4%

Adriamycin-associated

28.9%

10.7%

Neuromuscular disease

5.3%

3.1%

Single gene defect

2.6%

3.1%

Metabolic disorder

5.3%

1.5%

Mitochondrial disorder

0.0%

1.5%

Other

13.2%

13.7%

Known or suspected familial Cardiomyopathy

18.4%

16.0%

0.81
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Table 3

Congestive heart failure classification at baseline in 169 enrolled subjects.
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Partial
Participation

Full
Participation

Pvalue

9

45

1.00

I. No limitation or symptoms

77.8%

77.8%

II. Symptoms but no growth failure

11.1%

13.3%

III. Growth failure & prolonged feeding time in infants

11.1%

8.9%

IV. Growth failure & symptomatic at rest

0.0%

0.0%

Ross Classification (age < 5 years)

NYHA Classification (Age ≥ 5 years)

29

86

I. No limitation of activities; no symptoms from ordinary activities

72.4%

59.3%

II. Slight, mild limitation of activities; comfortable with rest or mild exertion

27.6%

38.4%

III. Marked limitation of activity; comfortable only at rest

0.0%

2.3%

IV. At complete rest; any physical activity brings on discomfort and symptoms occur at rest

0.0%

0.0%

NYHA = New York Heart Association

NIH-PA Author Manuscript
NIH-PA Author Manuscript
J Am Soc Echocardiogr. Author manuscript; available in PMC 2013 August 01.

0.46

Colan et al.

Page 22

Table 4

NIH-PA Author Manuscript

Percent (%) error for single-beat and 2- and 3-beat averaging methods for both inter- and intra-observer
reproducibility for all 150 variables.
Range (Median)
Averaging Method

Inter-observer % error

Intra-observer % error

1-beat

1.1 – 56.9 (11.4)

0.53 – 32.3 (6.3)

2-beat average

0.97 – 49.4 (10.2)

0.41 – 25.8 (4.9)

3-beat average

0.9 – 46.7 (9.3)

0.33 – 23.2 (4.2)
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Inter-observer mean % error

2D (3)
2D (4)

Biplane apical cardiac index

Biplane apical LV mass : volume ratio
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2D (4)

17.7

18.1

18.2

18.3

18.7

18.8

20.8

20.9

21.0

21.0

22.1

22.3

22.3

22.8

34.7

37.0

38.7

43.9

44.6

46.7

%
error

ntra-observer mean % error

2D (3)
2D (3)

Biplane apical cardiac output*

M-mode (2)

M-mode (4)

2D (4)

Doppler, time

Tissue Doppler, time (4)

2D (2)

Doppler, time (4)

LV end-systolic meridional wall stress

LV thickness to dimension ratio

LV velocity of circumferential fiber shortening

Biplane apical systemic vascular resistance*

Time between mitral regurgitation velocity of 1 and 3 m/sec

Septal STD Tei index

LV fractional shortening

Mitral and aortic valve simultaneous Tei index

2D (4)

Tissue Doppler, time (4)

Left STD Tei index*
LV velocity of circumferential fiber shortening*

Tissue Doppler, time (4)

Doppler, time (4)

Doppler, time

Tissue Doppler, slope

Color M-mode, slope

M-mode (4)

Tissue Doppler, slope

Doppler, time

Tissue Doppler, slope

Variable
type

Right STD Tei index*

Mitral and aortic valve separate Tei index*

Mitral valve early deceleration time*

Right STD isovolumic contraction period acceleration*

LV flow propagation velocity*

Mitral valve Tei index*

Septal STD isovolumic contraction period acceleration*

Duration of pulmonary vein flow reversal during atrial
systole*

Left STD isovolumic contraction period acceleration *

Variable name

2D = 2-dimensional; LV = left ventricle; STD = spectral tissue Doppler. For calculated variables, the number of variables used in the calculation is in parentheses.

Area-length systemic vascular resistance

Tissue Doppler, time (4)

2D (4)

Mod-Simpsons systemic vascular resistance

Left STD Tei index*

2D (4)

M-mode (3)

2D (4)

Doppler, time

2D (4)

Tissue Doppler, time (4)

Mod-Simpsons LV mass : volume ratio

LV end-systolic fiberstress

LV velocity of circumferential fiber shortening*

Biplane apical LV stroke volume

Mitral valve early deceleration time*

Right STD Tei index*

Doppler, time (4)

2D (3)

Biplane apical cardiac output*

Mitral and aortic valve separate Tei index*

2D (4)

Systemic resistance, biapical*

Doppler, time

Duration of pulmonary vein flow reversal during atrial
systole*
Color M-mode, slope

Tissue Doppler, slope

Right STD isovolumic contraction period acceleration*

LV flow propagation velocity*

Tissue Doppler, slope

M-mode (4)

Tissue Doppler, slope

Variable
type

Left STD isovolumic contraction period acceleration*

Mitral valve Tei index*

Septal STD isovolumic contraction period acceleration*

Variable name

Core laboratory measurements: Twenty variables with the highest mean inter- and intra-observer % error with 3-beat averaging.
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Table 5

8.6

8.9

8.9

9.1

9.4

9.5

9.6

10.3

11.1

11.5

13.3

15.3

15.5

15.8

17.6

17.8

20.6

21.3

22.4

23.2

%
error
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An asterisk‘*’ marks the variables that feature among the 20 variables for both the highest inter-observer and the highest intra-observer % error at the core laboratory.
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Inter-observer mean % error

M-mode

LV ED short axis dimension*

2D
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2D
2D

LV ED short axis epicardial area*

LV ED 4-ch long axis epicardial area*

4.8

4.7

4.7

4.6

4.5

4.5

4.4

4.3

4.2

4.2

4.0

4.0

3.9

3.8

3.8

3.7

3.6

3.2

3.2

0.90

%
error

Intra-observer mean % error

2D

LV ES 4-ch endocardial long axis dimension*

LV ED 2-chamber long axis endocardial area

2D

2D, 2

2D

LV ES short axis dimension*
Mod-Simpsons end-diastolic volume

2D, 2

M-mode

2D

2D

M-mode

2D

2D

2D, 2

2D

2D (2)

2D

2D

LV sphericity index

LV ES short axis dimension

LV ED 2-ch long axis epicardial area

LV ED short axis dimension*

LV ED short axis dimension*

LV ES 4-ch long axis endocardial area (2D)

LV ED 4-ch long axis endocardial area

Area-length end-systolic volume

LV ED 4-ch long axis epicardial area*

Area-length end-diastolic volume

LV ES short axis endocardial area

LV ED short axis endocardial area

2D

2D

LV ED 4-ch endocardial long axis dimension*

LV ED short axis epicardial area*

2D

2D

Variable
type

LV ED 4-ch epicardial long axis dimension*

LV function: Eccentricity index

Variable name

2.1

2.0

1.9

1.9

1.8

1.7

1.6

1.5

1.5

1.4

1.3

1.3

1.2

1.0

0.93

0.89

0.80

0.71

0.67

0.33

%
error

An asterisk ‘*’ marks the variables that feature among the 20 variables for both the lowest inter-observer and the lowest intra-observer % error at the core laboratory.

2D = two-dimensional; 2-ch = 2-chamber; 4-ch = 4-chamber; ED = end-diastolic; ES = end-systolic; LV = left ventricle; M = M-mode; STD: spectral tissue Doppler. For calculated variables, the number of
variables used to calculate these is in parentheses. Measurements of heart rate have been excluded from this table.

Tissue Doppler, velocity

Right STD peak systolic velocity

Tissue Doppler, time

Aortic annulus diameter

Right STD isovolumic contraction onset to isovolumic relaxation end

Tissue Doppler, time

2D

Doppler, velocity

Tissue Doppler, time

Septal STD ejection time

LV ES 4-ch endocardial long axis dimension*

Aortic valve: Peak velocity

Left STD isovolumic contraction onset to isovolumic relaxation end

Doppler, time

2D

LV ED 4-ch endocardial long axis dimension*

Simultaneous mitral and aortic valve Doppler: Ejection time

2D

LV ES short axis dimension*

Doppler, time

2D

LV ED short axis dimension*

Mitral valve closure time

2D

Doppler, time

Doppler, velocity

Tissue Doppler, time

2D

Variable
type

LV ED 4-ch long axis epicardial dimension*

Aortic valve ejection time

Mitral valve peak early diastolic velocity

Septal STD: Isovolumic contraction onset to isovolumic relaxation end*

LV function: Eccentricity index

Variable name

Core laboratory measurements: Twenty variables with the lowest inter- and intra-observer % error with 3-beat averaging.
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Comparison of local to core laboratory measurements. Percent (%) error for single-beat and 2- and 3-beat
averaging methods for reproducibility for all 119 variables.
Averaging Method

Range (median)

1-beat

1.7 – 58.4 (14.7)

2-beat average

1.6 – 56.9 (12.8)

3-beat average

1.6 – 56.4 (12.0)

NIH-PA Author Manuscript
NIH-PA Author Manuscript
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2D (3)

LVES meridional wall stress

J Am Soc Echocardiogr. Author manuscript; available in PMC 2013 August 01.
2D (3)

LV ES fiberstress

Aortic valve stroke volume

LVES wall thickness

Doppler (3)

M-mode

Doppler (3)

2D (4)

LV velocity of circumferential fiber shortening*

Aortic valve systemic resistance

Doppler time (4)

Tissue Doppler, time (4)

Left STD Tei index*

Mitral and aortic valve simultaneous Tei index

Tissue Doppler time (4)

2D (2)

LV thickness to dimension ratio

Right STD Tei index*

M-mode

Doppler, time (4)

LVED wall thickness

Mitral and aortic valve separate Tei index*

M-mode (2)

Color M-mode, slope

LV flow propagation velocity*

LV thickness to dimension ratio

Tissue Doppler, slope

Right STD isovolumic contraction acceleration*

M-mode (3)

Tissue Doppler, slope

Septal STD isovolumic contraction acceleration*

LVES fiberstress*

Tissue Doppler, slope

Left STD isovolumic contraction acceleration*

M-mode (4)

Doppler, time

Duration of pulmonary vein flow reversal during
atrial systole*

Mitral plus aortic valve: Tei index*

Variable type

Variable name

Variables with highest % error

23.0

23.1

23.2

23.2

23.5

23.9

24.3

25.5

25.6

26.2

26.8

29.2

31.6

31.6

34.5

35.3

36.6

37.4

39

56.4

%
error

Variables with lowest % error

Doppler time

2D

LVES short axis dimension**
Mitral valve closure time

2D

Tissue Doppler, time

Tissue Doppler, velocity

2D

Tissue Doppler, time

LV ES 4-ch endocardial long axis dimension**

Septal STD: Ejection time**

Left STD: Peak diastolic summation wave velocity

LV ED 4-ch epicardial long axis dimension**

**

Left STD: isovolumic contraction onset to isovolumic relaxation end

Tissue Doppler, time

Doppler, time

Mitral and aortic valve simultaneous Doppler: ejection time **
Septal STD: isovolumic contraction onset to isovolumic relaxation
end **

Doppler, time

Tissue Doppler, time

2D

Doppler velocity

2D

M-mode

2D

Doppler velocity

2D

M-mode

2D

Variable type

Aortic valve ejection time**

Right STD: isovolumic contraction onset to isovolumic relaxation
end**

LV ED 4-ch endocardial long axis dimension **

Mitral valve peak early velocity**

LV ED short axis epicardial area**

LV ES short axis dimension

LV ED short axis dimension**

Aortic valve peak velocity**

Aortic annulus diameter**

LV ED short axis dimension**

LV function: Eccentricity index

Variable name

Comparison of local to core laboratory measurements, listing the 20 variables with the highest and lowest % error with 3-beat averaging.
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Table 8

6.6

6.6

6.4

6.1

6.1

6.1

6

5.9

5.9

5.9

5.8

5.8

5.6

5.5

5.5

5.3

5.1

4.5

4.3

1.6

%
error
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In the right columns (Variables with the lowest inter-observer error), a double asterisk ‘**’ marks the variables that also feature among the 20 variables with the lowest inter-observer % error at the core
laboratory (Table 6).

In the left columns (20 variables with the highest inter-observer error), an asterisk (*) marks the variables that also feature among the 20 variables with the highest inter-observer % error at the core
laboratory (Table 6).

For calculated variables, the number of variables used to calculate these is in parentheses. 2D = 2-dimensional; 4-ch = 4-chamber; ED = end-diastolic; ES = end-systolic; STD = spectral tissue Doppler.
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8.7 (5.2)
5.5 (3.9)
40.5 (38.6)
8.9 (4.4)

22.2 (16.5)

13.2 (7.9)

19.1 (5.2)

35.9 (27.5)

10.8 (5.1)

9.9 (5.6)

4.0 (1.9)

C4

D

I

S

T

V

R

3.2 (1.6)

6.2 (4.3)

8.9 (4.4)

40.5 (38.6)

5.5 (3.9)

8.7 (5.2)

18.8 (14.0)

14.4 (10.9)

10.0 (7.0)

6.8 (5.1)

2.0 (0.8)

4.2 (2.7)

5.5 (2.5)

19.9 (16.3)

3.9 (2.4)

4.2 (2.1)

8.4 (5.2)

5.8 (3.7)

4.6 (2.5)

1.5 (0.9)

Core lab
intraobserver %
error

<.001

<.001

<.001

0.004

<.001

<.001

<.001

<.001

<.001

<.001

P-value
(local/core vs.
core interobserver %
error)*

<.001

<.001

<.001

<.001

0.018

<.001

<.001

<.001

<.001

<.001

P-value
(core inter- vs.
core intraobserver %
error)†

Core lab inter-observer vs. Core lab intra-observer %error based on 150 variables

Local vs. Core lab observer %error vs. Core lab inter-observer %error based on 119 variables

†

*

These have been classified using the schema detailed in the text, where A = area; C2, C3, C4 = calculated from 2, 3 and 4 variables respectively; D = dimension; I = integral; S = slope; T = Doppler time
interval; V = velocity, and R = heart rate. Local vs. core, core lab inter-observer and core lab intra-observer % error have been calculated for all classes of variables. Percent error statistics are based on data
from 150 variables unless otherwise noted.

2.9 (1.6)

6.2 (4.3)

18.8 (13.4)

13.1 (9.7)

10.1 (6.7)

13.6 (8.4)

20.8 (12.9)

C3

6.8 (5.1)

Core lab
interobserver
% error

Mean (median) of % error
Core lab
interobserver %
error (119
variables)

C2

9.7 (7.3)

Local vs. core
observer %
error (119
variables)

A

Variable
type

Comparison of 3-beat averaged mean and median of median % error for all variables.
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